Tag:
Antares Pharma
Latest Headlines
Latest Headlines
Pfizer to employ Antares drug-delivery tech for mystery product
Pfizer ( $PFE ) isn't exactly wallowing in self-pity now that its blockbuster cholesterol drug Lipitor faces generic competition. Now is the time to make deals, think of new ways to deliver drugs
FDA green-light's Antares' overactive bladder gel; Watson to sell it
Antares Pharma's ($AIS) new topical gel to treat overactive bladder will hit the U.S. commercial market in the spring. FDA approval for the drug variation was announced Dec. 8. Fellow New Jersey
Antares Pharma shares jump on upbeat PhIII results
Shares of Antares Pharma got a nice bounce after the developer touted positive late-stage data for its experimental bladder control gel therapy. And Antares says it's now on track to file an NDA for
